- call +1-201-465-4211
- email sales@mrinsights.biz
Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.
Scope of the Report:
This report studies the Circulating Tumor Cells (CTC) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells (CTC) market by product type and applications/end industries.
Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasing incidences of cance.
The global Circulating Tumor Cells (CTC) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells (CTC).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Market Segment by Applications, can be divided into
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Circulating Tumor Cells (CTC) Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells (CTC)
1.2 Classification of Circulating Tumor Cells (CTC) by Types
1.2.1 Global Circulating Tumor Cells (CTC) Revenue Comparison by Types (2017-2023)
1.2.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Types in 2017
1.2.3 Ex-Vivo Positive Selection
1.2.4 In-Vivo Positive Selection
1.2.5 Negative Selection
1.2.6 Microchips & Single Spiral Micro Channel
1.3 Global Circulating Tumor Cells (CTC) Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Global Circulating Tumor Cells (CTC) Market by Regions
1.4.1 Global Circulating Tumor Cells (CTC) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)
1.5 Global Market Size of Circulating Tumor Cells (CTC) (2013-2023)
2 Manufacturers Profiles
2.1 AdnaGen
2.1.1 Business Overview
2.1.2 Circulating Tumor Cells (CTC) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AdnaGen Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Apocell
2.2.1 Business Overview
2.2.2 Circulating Tumor Cells (CTC) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Apocell Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocep
2.3.1 Business Overview
2.3.2 Circulating Tumor Cells (CTC) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocep Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Canopus Bioscience
2.4.1 Business Overview
2.4.2 Circulating Tumor Cells (CTC) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Creatv Microtech
2.5.1 Business Overview
2.5.2 Circulating Tumor Cells (CTC) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ikonisys
2.6.1 Business Overview
2.6.2 Circulating Tumor Cells (CTC) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ikonisys Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.7 IV Diagnostics
2.7.1 Business Overview
2.7.2 Circulating Tumor Cells (CTC) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Miltenyi Biotech
2.8.1 Business Overview
2.8.2 Circulating Tumor Cells (CTC) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nanostring Technologies
2.9.1 Business Overview
2.9.2 Circulating Tumor Cells (CTC) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Rarecells Diagnostics
2.10.1 Business Overview
2.10.2 Circulating Tumor Cells (CTC) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Vitatex
2.11.1 Business Overview
2.11.2 Circulating Tumor Cells (CTC) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vitatex Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Circulating Tumor Cells (CTC) Market Competition, by Players
3.1 Global Circulating Tumor Cells (CTC) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells (CTC) Players Market Share
3.2.2 Top 10 Circulating Tumor Cells (CTC) Players Market Share
3.3 Market Competition Trend
4 Global Circulating Tumor Cells (CTC) Market Size by Regions
4.1 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
4.3 Europe Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
4.5 South America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
5 North America Circulating Tumor Cells (CTC) Revenue by Countries
5.1 North America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)
5.2 USA Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
5.3 Canada Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
5.4 Mexico Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
6 Europe Circulating Tumor Cells (CTC) Revenue by Countries
6.1 Europe Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)
6.2 Germany Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
6.3 UK Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
6.4 France Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
6.5 Russia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
6.6 Italy Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)
7.2 China Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
7.3 Japan Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
7.4 Korea Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
7.5 India Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
8 South America Circulating Tumor Cells (CTC) Revenue by Countries
8.1 South America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)
8.2 Brazil Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
8.3 Argentina Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
8.4 Colombia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Circulating Tumor Cells (CTC) by Countries
9.1 Middle East and Africa Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
9.3 UAE Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
9.4 Egypt Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
9.6 South Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)
10 Global Circulating Tumor Cells (CTC) Market Segment by Type
10.1 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Type (2013-2018)
10.2 Global Circulating Tumor Cells (CTC) Market Forecast by Type (2018-2023)
10.3 Ex-Vivo Positive Selection Revenue Growth Rate (2013-2023)
10.4 In-Vivo Positive Selection Revenue Growth Rate (2013-2023)
10.5 Negative Selection Revenue Growth Rate (2013-2023)
10.6 Microchips & Single Spiral Micro Channel Revenue Growth Rate (2013-2023)
11 Global Circulating Tumor Cells (CTC) Market Segment by Application
11.1 Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2013-2018)
11.2 Circulating Tumor Cells (CTC) Market Forecast by Application (2018-2023)
11.3 Tumorigenesis Research Revenue Growth (2013-2018)
11.4 Emt Biomarkers Development Revenue Growth (2013-2018)
11.5 Cancer Stem Cell Research Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Circulating Tumor Cells (CTC) Market Size Forecast (2018-2023)
12.1 Global Circulating Tumor Cells (CTC) Market Size Forecast (2018-2023)
12.2 Global Circulating Tumor Cells (CTC) Market Forecast by Regions (2018-2023)
12.3 North America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)
12.4 Europe Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)
12.6 South America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Circulating Tumor Cells (CTC) Picture
Table Product Specifications of Circulating Tumor Cells (CTC)
Table Global Circulating Tumor Cells (CTC) and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
